Most upside comes from scaling into a much larger revenue base, not from keeping today’s scarcity premium. If CoreWeave proves it can turn
backlog into live workloads, keep financing available at lower spreads, and attach more software and trust features to
inference-heavy deployments, the stock can compound strongly even while its terminal valuation normalizes.